Clinical Trial Update: Phase 1 Study Into Pharmacokinetics and Food Effect of Vapendavir in Healthy Participants and Participants With COPD [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and food-effect study of Vapendavir in healthy participants and participants with COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Vapendavir (vapendavir)

Snippet

Sponsor: Altesa Biosciences, Inc. | Conditions: COPD, Respiratory Disease | Phase 1 | Status: COMPLETED